← Eichor
Study identifier: NCT07220941 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Digital Intervention for Adults With Misophonia: A Randomized Controlled Trial

Condition: Misophonia  ·  Sponsor: Utah State University

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to test an online intervention for adults with misophonia. The main questions it aims to answer are: 1. Is the online intervention effective, compared to a waitlist control condition? 2. Is the online intervention acceptable to use? Participants will be randomized into either the online intervention or waitlist control condition: 1. Participants in the intervention condition will be asked to complete an 8 module acceptance and commitment therapy (ACT) program for misophonia and 5 surveys over 4 months. 2. Participants in the waitlist condition will be asked to complete 5 surveys over 4 months, and will receive access to the intervention once the study is complete.

This description comes directly from the study's public registry record.

Talk to the study team

Emily M Bowers, M.S.  ·  781-686-6091  ·  emily.bowers@usu.edu

Michael P Twohig, PhD  ·  435-265-8933  ·  michael.twohig@usu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Utah State UniversityLogan, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07220941